STACEY ANDERSON: Open Payments
NPI 1427089333 · LAWRENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 24 payments from 9 companies in 2025. Trend: 2023 $903 · 2024 $0 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $143 |
| Novo Nordisk Inc | 5 | $84 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
| Amgen Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Gilead Sciences, Inc. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: UBRELVY, QULIPTA, Ozempic, Rybelsus, Symbravo, The Cologuard Plus Collection Kit, Wegovy, OTEZLA.
Industry payments across KS — which companies pay providers there.
